These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25750973)

  • 1. Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
    Knackstedt TJ; Quitadamo M
    Cutis; 2015 Feb; 95(2):E20-3. PubMed ID: 25750973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Philipp-Dormston WG
    Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of imiquimod in the treatment of periocular tumours.
    Ross AH; Kennedy CT; Collins C; Harrad RA
    Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Photodynamic therapy vs imiquimod].
    Serra-Guillén C; Nagore E; Guillén C
    Actas Dermosifiliogr; 2012; 103(6):488-501. PubMed ID: 22178262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma.
    Newman MD; Weinberg JM
    Cutis; 2007 Apr; 79(4 Suppl):18-28. PubMed ID: 17508492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients.
    Waalboer-Spuij R; Holterhues C; van Hattem S; Schuttelaar ML; Gaastra MT; Kuijpers DI; Hollestein LM; Nijsten TE
    Dermatology; 2015; 231(1):56-62. PubMed ID: 25925162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy.
    Banzhaf CA; Themstrup L; Ring HC; Mogensen M; Jemec GB
    Skin Res Technol; 2014 May; 20(2):170-6. PubMed ID: 24103017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond a decade of 5% imiquimod topical therapy.
    A Gaspari A; Tyring SK; Rosen T
    J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
    Akkilic-Materna M; Massone C; Komericki P
    Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating skin cancer with topical cream.
    Micali G; Lacarrubba F; Dinotta F; Massimino D; Nasca MR
    Expert Opin Pharmacother; 2010 Jun; 11(9):1515-27. PubMed ID: 20408746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapeutic options for actinic keratosis and basal cell carcinoma.
    Sligh JE
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S76-80. PubMed ID: 25268601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
    Love WE; Bernhard JD; Bordeaux JS
    Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions.
    Cannon PS; O'Donnell B; Huilgol SC; Selva D
    Br J Ophthalmol; 2011 Dec; 95(12):1682-5. PubMed ID: 20702431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local reactions to imiquimod in the treatment of basal cell carcinoma.
    Tandon Y; Brodell RT
    Dermatol Online J; 2012 Sep; 18(9):1. PubMed ID: 23031368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imiquimod cream. A cream to use with precaution].
    Taeron C
    Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
    [No Abstract]   [Full Text] [Related]  

  • 16. A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis.
    Neugebauer R; Levandoski KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
    J Am Acad Dermatol; 2018 Apr; 78(4):710-716. PubMed ID: 29277731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New perspective in immunotherapy: local imiquimod treatment].
    Kemény L; Nagy N
    Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
    Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
    Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of actinic keratoses.
    Shoimer I; Rosen N; Muhn C
    Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.